Adding year-end urgency to the national debate over stem cells, a prominent UC Davis researcher is asking federal officials to send warning letters to hundreds of stem cell clinics nationwide that he contends are selling patients risky, unproven therapies.
Citing uncertainty over how the incoming Trump administration will handle stem cell use, professor Paul Knoepfler, a stem cell researcher at the UC Davis Medical School, said “now is the time” for the U.S. Food and Drug Administration to finalize guidelines and send notices to clinics that are offering untested treatments.
“There’s a closing window of time, prior to the (Donald) Trump inauguration, when the FDA could take action and have a positive impact by reining things in that have gotten out of control,” said Knoepfler. “These clinics are operating outside the normal scope of FDA oversight.”
Continue reading the full article on Sacramento Bee...
Image via Public Domain Pictures
This site contains copyrighted material the use of which has not always
been specifically authorized by the copyright owner. We are making such
material available in our efforts to advance understanding of
biotechnology and public policy issues. We believe this constitutes a
'fair use' of any such copyrighted material as provided for in section
107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section
107, the material on this site is distributed without profit to those
who have expressed a prior interest in receiving the included
information for research and educational purposes. For more information
go to: http://www.copyright.gov/title17/92chap1.html#107. If you wish to use
copyrighted material from this site for purposes of your own that go
beyond 'fair use', you must obtain permission from the copyright owner.